The frequencies of PI3K rs121913281 in breast cancer cases was CC (26.54%), CT (51.32%), and TT (22.12%), compared to gender matched controls who were more likely to have frequencies of CC (16.66%), CT (79.41%), and TT (3.92%), respectively (Table 3). This evidence concerns the gene PIK3CG and breast carcinoma.